CD34+ Enriched Transplant

A Phase II Trial of CD34+ Enriched Transplants From HLA-Compatible Related or Unrelated Donors for Treatment of Patients With Myelodysplastic Syndrome

More Information

Trial Status
Not currently accepting
Trial Phase
Phase 2
Enrollment
50 patients (estimated)
Tags
Allogeneic Stem Cell Transplant, T Cell, CD34
Trial Type
Treatment
Last Update
2 months ago
SparkCures ID
1497
NCT Identifier
NCT05617625

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.